Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery

Código QR

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery

Sang Joon Lee,1,* Young-Il Jeong,2,* Hyung-Kyu Park,3 Dae Hwan Kang,2,4 Jong-Suk Oh,3 Sam-Gyu Lee,5 Hyun Chul Lee31Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju, 2Biomedical Research Institute, Pusan National University Hospital, Busan, 3Department of Microbi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lee SJ, Jeong YI, Park HK, Kang DH, Oh JS, Lee SG, Lee HC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/283c8539a2df43d7ab6a298a45944c66
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
por: Alimoradi H, et al.
Publicado: (2018)

Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery
por: Lee JY, et al.
Publicado: (2014)

Aspirin-Based Organoiron Dendrimers as Promising Anti-Inflammatory, Anticancer, and Antimicrobial Drugs
por: Alaa S. Abd-El-Aziz, et al.
Publicado: (2021)

Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs
por: Choi J, et al.
Publicado: (2015)

Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity
por: Shao N, et al.
Publicado: (2011)

Polyanionic carbohydrate doxorubicin&ndash;dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations
por: Yousefpour P, et al.
Publicado: (2011)

Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications
por: Kalomiraki M, et al.
Publicado: (2015)

Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system
por: Barahuie F, et al.
Publicado: (2017)

Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release
por: Men W, et al.
Publicado: (2019)

Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats.
por: Kishore Golla, et al.
Publicado: (2012)

Noncovalent interaction-assisted drug delivery system with highly efficient uptake and release of paclitaxel for anticancer therapy
por: Wei YP, et al.
Publicado: (2017)

Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications
por: Mona Ebadi, et al.
Publicado: (2020)

Functionalized Graphene Platforms for Anticancer Drug Delivery
por: Sattari S, et al.
Publicado: (2021)

Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery
por: Tsolou A, et al.
Publicado: (2020)

Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy
por: Heo MB, et al.
Publicado: (2015)

Dextran-b-poly(L-histidine) copolymer nanoparticles for pH-responsive drug delivery to tumor cells
por: Hwang JH, et al.
Publicado: (2013)

Forgotten coindex of some non-toxic dendrimers structure used in targeted drug delivery
por: Ali Yasir, et al.
Publicado: (2021)

Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles
por: Li SJ, et al.
Publicado: (2017)

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou X, et al.
Publicado: (2012)

Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy
por: Lee PC, et al.
Publicado: (2019)

Pharmacokinetics of peptide mediated delivery of anticancer drug ellipticine.
por: Weina Ma, et al.
Publicado: (2012)

Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin
por: Masarudin MJ, et al.
Publicado: (2015)

Liquid crystal nanoparticle formulation as an oral drug delivery system for liver-specific distribution
por: Lee DR, et al.
Publicado: (2016)

Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance
por: Zhang DD, et al.
Publicado: (2017)

Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
por: Dąbkowska M, et al.
Publicado: (2019)

Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
por: Chen Y, et al.
Publicado: (2011)

Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
por: Masarudin MJ, et al.
Publicado: (2016)

Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery
por: Yu X, et al.
Publicado: (2016)

PEGylated Doxorubicin Prodrug-Forming Reduction-Sensitive Micelles With High Drug Loading and Improved Anticancer Therapy
por: Dongdong Wang, et al.
Publicado: (2021)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen M, et al.
Publicado: (2019)

PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
por: Fana M, et al.
Publicado: (2020)

Dendrimers bind antioxidant polyphenols and cisplatin drug.
por: Amine Abderrezak, et al.
Publicado: (2012)

Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug
por: Wang H, et al.
Publicado: (2014)

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
por: Li Y, et al.
Publicado: (2017)

Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin
por: Akbarzadeh A, et al.
Publicado: (2012)

Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation
por: Lee P, et al.
Publicado: (2012)

Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin [Retraction]
por: Akbarzadeh A, et al.
Publicado: (2019)

A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery
por: Yang CL, et al.
Publicado: (2018)

Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
por: Xue H, et al.
Publicado: (2019)

Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
por: Xue H, et al.
Publicado: (2017)